Company: PGEN
Filing Date: 2025-03-19
Form Type: 10-K
Source: 0001356090-25-000007
Chunk: 157

Company: PRECIGEN, INC.
Filing Date: 2025-03-19
Form: 10-K
Item: Item 12
Chunk 157
---
s in thousands, except share and per share data)202420232022RevenuesCollaboration and licensing revenues, including $14,561 from related parties in 2022.$— $75 $14,661 Product revenues422 840 1,903 Service revenues3,470 5,301 10,094 Other revenues33 9 251 Total revenues3,925 6,225 26,909 Operating ExpensesCost of products and services4,267 6,119 6,339 Research and development53,070 48,614 47,170 Selling, general and administrative41,293 40,415 48,006 Impairment of goodwill7,409 10,390 482 Impairment of other noncurrent assets32,915 445 638 Total operating expenses138,954 105,983 102,635 Operating loss(135,029)(99,758)(75,726)Other Income (Expense), NetInterest expense(6)(468)(6,774)Interest income1,418 3,237 133 Other income, net5,589 627 1,539 Total other income (expense), net7,001 3,396 (5,102)Equity in net income of affiliates— — 862 Loss from continuing operations before income taxes(128,028)(96,362)(79,966)Income tax benefit1,793 458 189 Loss from continuing operations(126,235)(95,904)(79,777)Income from discontinued operations, net of income tax benefit— — 108,094 Net (loss) income$(126,235)$(95,904)$28,317 Net (Loss) Income per ShareNet loss from continuing operations per share, basic and diluted$(0.47)$(0.39)$(0.40)Net income from discontinued operations per share, basic and diluted— — 0.54 Net (loss) Income per share, basic and diluted$(0.47)$(0.39)$0.14 Weighted average shares outstanding, basic and diluted267,727,426 244,536,221 200,360,821 

The accompanying notes are an integral part of these consolidated financial statements.

F-7

Precigen, Inc. and Subsidiaries

Consolidated Statements of Comprehensive (Loss) Income

Years